09Sep 2023
Novel Spatial Profiling Technique Identifies Tumor Microenvironment Markers for Triple-Negative Breast Cancer

Novel Spatial Profiling Technique Identifies Tumor Microenvironment Markers for Triple-Negative Breast Cancer

A groundbreaking approach for spatial molecular profiling has emerged in response to the growing significance of the tumor microenvironment (TME) in immuno-oncology. This technology fills the gaps left by conventional methods, revealing compartmentalized heterogeneity crucial for predicting drug resistance and patient response in cancer treatment. A recent study introduced a novel assay-agnostic method, successfully identifying immune microenvironment signatures in breast cancer patients. Notably, it outperformed FDA-approved companion diagnostic tests, revealing two distinct physiological states unrelated to conventional markers like tumor mutational burden and PD-L1 expression.

  • #oncology

Like

Save

Share